RNAi|omicsgroup|Gene Technology

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Gene Technology is one of the leading Scholarly journals in Modern Biotechnology. The journal strives to add in theoretical and technological innovations as part of its publishing remit and is devoted to publishing the highest quality papers. The administration of the journal is integrative, reflecting the fact that imaging neuroscience is a multi-disciplinary science. The regulators of RNAi pathway and therapeutic application, the chemical biology approach has been applied on the basis of screening large amount of small molecule drug library in recent years. Basically, large number of clinical small molecule compounds approved by FDA have been collected and the generated libraries have been available commercially in the format of 96-well plates, such as the NINDS and Prestwick libraries, providing access to mostly FDA-approved and marketed drugs as the priceless source for small molecule screening with focus of new uses for old drugs. “Yujing Li, Chemical Biology Approach for Dissection of RNAi/miRNA Pathway” OMICS is devoted to the prompt publication of original findings of the highest scientific priority and value that provide novel mechanistic insights, represent a clear advance over previous Studies and have the potential to generate exciting future research.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2021